Robert C. Ducommun, a director at Ducommun Inc . (NYSE:DCO), has reported selling 1,000 shares of the company's common stock. The transaction, which took place on December 5, 2024, was executed at a price of $69.50 per share, amounting to a total sale value of $69,500. The sale occurred near the stock's 52-week high of $70.50, with analysts setting price targets between $80-89, according to InvestingPro data. Following this transaction, Ducommun holds 409,900 shares directly. Additionally, he maintains indirect ownership of shares through various family-related accounts, including holdings by his daughter, grandchildren, and wife, as well as shares in his IRA account. The company, valued at approximately $943 million, maintains strong liquidity with a current ratio of 3.21 and receives a FAIR overall financial health rating from InvestingPro, which offers comprehensive analysis through its Pro Research Report covering 1,400+ US stocks.
In other recent news, Ducommun Incorporated reported a record revenue of $201.4 million in its third quarter 2024 earnings call, marking a 2.6% increase from the same period last year. The company's growth was primarily driven by the military and space sectors, with commercial aerospace also showing a significant rise. Ducommun's gross margins improved due to strategic pricing and operational efficiencies, and the adjusted EBITDA reached $31.9 million. Despite a slowdown in Boeing-related programs, Ducommun's backlog grew substantially. The management remains optimistic about future growth, particularly in commercial aerospace and defense. These developments are recent and show a promising trajectory for Ducommun Incorporated. The company expects a revenue growth between 3% to 4% for the full year 2024. Analysts from the earnings call highlighted the company's Vision 2027 strategy, which focuses on engineered products and operational optimization. They also noted the anticipated recovery in Boeing (NYSE:BA) production rates by 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.